PROSITE logo

PROSITE documentation PDOC52081
CPH (CUL7, PARC, and HERC2) domain profile


View entry in original PROSITE document format
View entry in raw text format (no links)
PURL: https://purl.expasy.org/prosite/documentation/PDOC52081

Description

The p53 tumor suppressor responds to cellular stress by inducing apoptosis, senescence, and growth arrest. Regulation of stress responses by p53 is primarily mediated through its action as a transcription factor. The predominant mechanisms controlling p53 function are regulation of its protein stability, subcellular localization, and post-translational modification. Ubiquitin-mediated proteasomal targeting of p53 serves to regulate p53 protein levels. The tetramerization domain (TD) of p53 has been implicated in multiple aspects of p53 function including sequence-specific DNA binding, subcellular localization, and protein-protein interactions [1,2,3,4,5].

Ubiquitination involves a cascade of enzymes beginning with activation of ubiquitin by the E1 ubiquitin-activating enzyme. Following activation, ubiquitin is transferred first to an E2 ubiquitin conjugating enzyme and then to an E3 ubiquitin ligase. E3 ligases serve to recruit specific substrates for subsequent poly-ubiquitination. E3 ubiquitin ligases have been classified into two main types: HECT and RING [1,2,3,4,5].

The RING E3 ubiquitin ligases Cullin 7 (CUL7) and Parkin-like cytoplasmic (PARC, also known as Cullin 9), and the HECT E3 ubiquitin ligase HECT- and RCC1-like domains 2 (HERC2) contain a common domain named CPH (a conserved domain within Cul7, PARC, and HERC2 proteins). CPH domains are protein-protein interaction modules that bind the TD of p53. Proteins with a CPH domain bind p53 and regulate its activity in different ways. Thus, whereas CUL7 and PARC promote cell growth by antagonizing p53 functions, HERC2 activates p53, thus inhibiting cell cycle progression [1,2,3,4,5].

The CPH domain has a β-barrel architecture consisting of five antiparallel β-strands, three loops, and an α-helix. Strands β1-β2 are connected by a long turn, β2-β3 and β3-β4 are connected by a short turn, whereas strands β4 and β5 are linked by a helical turn (see <PDB:2JNG>). The arrangement of β sheets in the CPH domain is almost identical to that found in SH3, Tudor, and KOW domains. Nevertheless, there is significant variability in the length and arrangement of the loops that contribute to peptide binding in each domain. Furthermore, despite the similar fold, all three domains display variety in the location of functional binding sites. Thus, each module uses the same fold in a unique manner to interact with partners [3].

The profile we developed covers the entire CPH domain.

Last update:

November 2025 / First entry.

-------------------------------------------------------------------------------


Technical section

PROSITE method (with tools and information) covered by this documentation:

CPH, PS52081; CPH (CUL7, PARC, and HERC2) domain profile  (MATRIX)


References

1AuthorsKasper J.S. Arai T. DeCaprio J.A.
TitleA novel p53-binding domain in CUL7.
SourceBiochem. Biophys. Res. Commun. 348:132-138(2006).
PubMed ID16875676
DOI10.1016/j.bbrc.2006.07.013

2AuthorsAndrews P. He Y.J. Xiong Y.
TitleCytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.
SourceOncogene 25:4534-4548(2006).
PubMed ID16547496
DOI10.1038/sj.onc.1209490

3AuthorsKaustov L. Lukin J. Lemak A. Duan S. Ho M. Doherty R. Penn L.Z. Arrowsmith C.H.
TitleThe conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53.
SourceJ. Biol. Chem. 282:11300-11307(2007).
PubMed ID17298945
DOI10.1074/jbc.M611297200

4AuthorsCubillos-Rojas M. Amair-Pinedo F. Peiro-Jordan R. Bartrons R. Ventura F. Rosa J.L.
TitleThe E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.
SourceJ. Biol. Chem. 289:14782-14795(2014).
PubMed ID24722987
DOI10.1074/jbc.M113.527978

5AuthorsGarcia-Cano J. Sanchez-Tena S. Sala-Gaston J. Figueras A. Vinals F. Bartrons R. Ventura F. Rosa J.L.
TitleRegulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2.
SourceMol. Oncol. 14:69-86(2020).
PubMed ID31665549
DOI10.1002/1878-0261.12592



PROSITE is copyrighted by the SIB Swiss Institute of Bioinformatics and distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0) License, see prosite_license.html.